These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 33736696

  • 1. Timing of antiretroviral therapy for HIV-infected patients with cytomegalovirus retinitis: study protocol of a multi-center prospective randomized controlled trial.
    He XQ, Huang YQ, Zeng YM, Qin YY, Tang SQ, Xu XL, Harypursat V, Lu YQ, Liu M, Yuan J, Chen YK.
    Trials; 2021 Mar 18; 22(1):218. PubMed ID: 33736696
    [Abstract] [Full Text] [Related]

  • 2. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections: Study protocol for antiretroviral therapy timing in AIDS patients with toxoplasma encephalitis.
    Zeng YM, Li Y, He XQ, Huang YQ, Liu M, Yuan J, Bai Y, Lu YQ, Li H, Chen YK.
    Medicine (Baltimore); 2020 Jul 17; 99(29):e21141. PubMed ID: 32702867
    [Abstract] [Full Text] [Related]

  • 3. Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial.
    Qin Y, Lu Y, Zhou Y, Harypursat V, Sun F, Yang S, Tang S, Li Y, He X, Zeng Y, Chen Y.
    Trials; 2020 Jun 22; 21(1):551. PubMed ID: 32571429
    [Abstract] [Full Text] [Related]

  • 4. Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study.
    Zeng YM, Li Y, Lu YQ, Liu M, Nie JM, Yuan J, Harypursat V, Zhou YH, Qin YY, Chen XH, Zhang YL, Zhang DF, Wang N, Chen H, Tian Q, Zhou Y, Qin YM, Yang XP, Chen YK.
    BMC Pulm Med; 2022 Aug 25; 22(1):323. PubMed ID: 36008855
    [Abstract] [Full Text] [Related]

  • 5. [Clinical characteristic and treatment of cytomegalovirus retinitis in 80 patients with acquired immunodeficiency syndrome].
    Yang Y, Jiang R, He T, Lu H, Zhang R, Shen Y, Zheng Y, Liu L, Wang W.
    Zhonghua Yan Ke Za Zhi; 2014 Mar 25; 50(3):197-202. PubMed ID: 24841816
    [Abstract] [Full Text] [Related]

  • 6. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM, Membrey WL, Youle MS, Obi A, Worrell S, Gazzard BG.
    Br J Ophthalmol; 1999 Jun 03; 83(6):652-5. PubMed ID: 10340970
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa.
    Hassan-Moosa R, Chinappa T, Jeena L, Visser L, Naidoo K.
    S Afr Med J; 2017 Sep 22; 107(10):843-846. PubMed ID: 29022526
    [Abstract] [Full Text] [Related]

  • 9. Clinical Features and CD4+ T Cells Count in AIDS Patients with CMV Retinitis: Correlation with Mortality.
    Agrawal R, Gunasekeran DV, Xu Y, Leo YS, Ng OT, Wong CS, Testi I, Ding J, Banu I, Teoh SC.
    Ocul Immunol Inflamm; 2022 Jan 02; 30(1):42-47. PubMed ID: 32644842
    [Abstract] [Full Text] [Related]

  • 10. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
    Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S, Studies of the Ocular Complications of AIDS Research Group.
    Ophthalmology; 2010 Nov 02; 117(11):2152-61.e1-2. PubMed ID: 20673591
    [Abstract] [Full Text] [Related]

  • 11. Proposed clinical case definition for cytomegalovirus-immune recovery retinitis.
    Ruiz-Cruz M, Alvarado-de la Barrera C, Ablanedo-Terrazas Y, Reyes-Terán G.
    Clin Infect Dis; 2014 Jul 15; 59(2):298-303. PubMed ID: 24771331
    [Abstract] [Full Text] [Related]

  • 12. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.
    van den Horn GJ, Meenken C, Danner SA, Reiss P, de Smet MD.
    Br J Ophthalmol; 1998 Sep 15; 82(9):988-90. PubMed ID: 9893585
    [Abstract] [Full Text] [Related]

  • 13. Ocular involvement in highly treatment-experienced patients with HIV.
    Cobaschi M, Dorobăț CM, Dorobăț VD, Loghin II, Macovei ML, Marinescu A, Aramă V.
    Rom J Ophthalmol; 2024 Sep 15; 68(2):152-157. PubMed ID: 39006338
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.
    HIV Clin Trials; 2006 Sep 15; 7(1):1-9. PubMed ID: 16632459
    [Abstract] [Full Text] [Related]

  • 18. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF, Mendoza AJ, Ferretti Y.
    Retina; 2003 Aug 15; 23(4):495-502. PubMed ID: 12972761
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.